TONADOPGENE PARVEC
UNII 4CSX868T8S

Substance Identification & Data

This profile provides standardized clinical and technical data for Tonadopgene Parvec, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 4CSX868T8S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3053586-07-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

4CSX868T8S

CAS Registry Number

3053586-07-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TONADOPGENE PARVEC

Official standardized name for this substance within the FDA UNII nomenclature system.

INN ID

13829

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

structurallyDiverse

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tonadopgene Parvec. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TONADOPGENE PARVEC

Common Names & Synonyms

RECOMBINANT NON-REPLICATING ADENO-ASSOCIATED VIRUS SEROTYPE 2 (RAAV2) VECTOR ENCODING HUMAN AROMATIC L-AMINO ACID DECARBOXYLASE (AADC, DDC, DOPA DECARBOXYLASE) UNDER CONTROL OF A CYTOMEGALOVIRUS (CMV) IMMEDIATE-EARLY (IE) ENHANCER/PROMOTER AND A HUMAN .BETA.-GLOBIN INTRON AND TERMINATED BY A HUMAN GROWTH HORMONE POLYADENYLATION SIGNAL; FLANKED BY AAV2 INVERTED TERMINAL REPEATS (ITRS)

TONADOPGENE PARVEC [INN]

External Clinical & Regulatory Resources

Previous UNII4CSJ8BJ597

Next UNII4CT05287VQ